Zurcher Kantonalbank »

First Tracks Biotherapeutics shares owned by Zurcher Kantonalbank

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Zurcher Kantonalbank from 13F filings

Historical chart of Zurcher Kantonalbank investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Zurcher Kantonalbank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Zurcher Kantonalbank

Quarter filed Position value Share count Share price at filing
2026-06-30 $131k 6.5k 20.12

More positions owned by Zurcher Kantonalbank

NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Micron Technology (MU)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Amrize SHS (AMRZ)
Alcon Ord Shs (ALC)

View all positions for Zurcher Kantonalbank

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics